Cover Image
市場調查報告書

多重化驗市場:各類型 (核酸為基礎的/蛋白質為基礎的多重化驗、其他)、各產品、各技術、各用途、各終端用戶:全球機會分析與產業預測

Multiplex Assays Market by Type (Nucleic Acid-Based/Protein-Based Multiplex Assays, and Other Multiplex Assays}, Product, Technology, Application, and End User - Global Opportunity Analysis and Industry Forecast, 2014-2022

出版商 Allied Market Research 商品編碼 498827
出版日期 內容資訊 英文 180 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
多重化驗市場:各類型 (核酸為基礎的/蛋白質為基礎的多重化驗、其他)、各產品、各技術、各用途、各終端用戶:全球機會分析與產業預測 Multiplex Assays Market by Type (Nucleic Acid-Based/Protein-Based Multiplex Assays, and Other Multiplex Assays}, Product, Technology, Application, and End User - Global Opportunity Analysis and Industry Forecast, 2014-2022
出版日期: 2017年04月01日 內容資訊: 英文 180 Pages
簡介

本報告提供全球多重化驗市場相關調查,市場概要,各類型、各產品、各技術、各用途、各終端用戶、各地區的趨勢,及加入此市場的主要企業簡介等彙整資料。

第1章 簡介

第2章摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 主要調查結果
  • 波特五力分析
  • 市場佔有率分析
  • 法律規章
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會

第4章 各類型市場

  • 概要
  • 核酸為基礎
  • 蛋白質為基礎
  • 其他

第5章 各產品市場

  • 概要
  • 試劑及消耗品
  • 設備及配件
  • 軟體及服務

第6章 各技術市場

  • 概要
  • 多重PCR
  • 多重蛋白質微陣列
  • 其他

第7章 各用途市場

  • 概要
  • 搭配診斷
  • 研究開發
  • 臨床診斷

第8章 各終端用戶市場

  • 概要
  • 醫院
  • 臨床試驗所
  • 研究機關
  • 製藥公司、生物科技企業

第9章 各地區市場

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美

第10章 企業簡介

目錄
Product Code: LI 171921

Intraocular lenses (IOLs) are a type of ophthalmic implants, which are used in surgeries pertaining to eyes. IOLs are synthetic lenses implanted inside the eye that substitute the focusing power of a natural lenses, which are surgically removed. These are used to treat myopia, astigmatism, or cataracts.

The global intraocular lens market generated $3,306 million in 2015, and is projected to reach $4,973 million by 2022, registering a CAGR of 7.0% during the study period. In terms of volume, the market is expected to grow at a CAGR of 7.1%. This is attributed to rise in geriatric population, increase in prevalence of cataract, and rise in initiatives taken by government to eliminate avoidable blindness. Moreover, rise in adoption of premium lens owing to their enhanced visual performance ensures reduced rates of astigmatism, thus supplementing the growth of the market. However, unfavorable reimbursement scenario for premium lens and postoperative complications such as refractive errors are expected to restrain the market growth.

The intraocular lens market is segmented based on type, material, end user, and geography. On the basis of type, the market is bifurcated into monofocal and premium intraocular lens. The premium intraocular lens is sub-segmented into toric, multifocal, accommodating, and others (blue light filtering, phakic, and aspheric intraocular lens). By material, the market is categorized into polymethylmethacrylate (PMMA), silicone, and hydrophobic acrylic. According to end user, it is divided into hospitals, ambulatory surgical centers, ophthalmology clinics, and eye research institutes. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Prominent players adopted product development and product launches & approvals as their key developmental strategies to expand their product portfolio. For instance, in July 2016, Abott Medical Optics (now acquired by Johnson & Johnson) received FDA approval for the use of Tecnis Symfony Intraocular lenses for the treatment of cataract.

KEY BENEFITS

  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the global intraocular lens market.
  • This study provides the competitive landscape of the global market to predict the competitive environment across geographies.
  • This report entails the detailed quantitative analysis of the current trends and future estimations to identify the prevailing opportunities.
  • Comprehensive analysis of factors that drive and restrict the market growth is provided in the report.
  • Region- and country-wise analysis is provided to understand the market trends and dynamics.

KEY MARKET SEGMENTS

By Type

  • Monofocal Intraocular Lens
  • Premium Intraocular Lens
  • Toric Intraocular Lens
  • Multifocal Intraocular Lens
  • Accommodating Intraocular Lens
  • Others
  • Blue Light Filtering Intraocular Lens
  • Phakic Intraocular Lens
  • Aspheric Intraocular Lens

By Material

  • Polymethylmethacrylate (PMMA)
  • Silicone
  • Hydrophobic Acrylic

By End User

  • Hospitals
  • Ambulatory Surgery Centers
  • Ophthalmology Clinics
  • Eye Research Institutes

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Netherlands
    • Norway
    • Russia
    • Sweden
    • Switzerland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • New Zealand
    • Taiwan
    • Thailand
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Chile
    • Columbia
    • Egypt
    • Iran
    • Israel
    • Turkey
    • Venezuela
    • Rest of LAMEA

Table of Contents

CHAPTER 1 - INTRODUCTION

  • 1.1. KEY BENEFITS
  • 1.2. KEY MARKET SEGMENTS
  • 1.3. RESEARCH METHODOLOGY
    • 1.3.1. Secondary research
    • 1.3.2. Primary research
    • 1.3.3. Analyst tools and models

CHAPTER 2 - EXECUTIVE SUMMARY

  • 2.1. KEY FINDINGS OF THE STUDY
  • 2.2. CXO PERSPECTIVE

CHAPTER 3 - MARKET OVERVIEW

  • 3.1. MARKET DEFINITION AND SCOPE
  • 3.2. KEY FINDINGS
    • 3.2.1. Top winning strategies
    • 3.2.2. Top investment pockets
  • 3.3. MARKET SHARE ANALYSIS, 2015
  • 3.4. MARKET DYNAMICS
    • 3.4.1. Drivers
      • 3.4.1.1. Increasing prevalence of cataract
      • 3.4.1.2. Rise in adoption of premium intraocular lens
      • 3.4.1.3. Increasing government initiatives
      • 3.4.1.4. Increasing pool of geriatric population susceptible to ocular conditions
      • 3.4.1.5. Growing number of diabetic patients
    • 3.4.2. Restraints
      • 3.4.2.1. Post-operative complications
      • 3.4.2.2. Lack of coverage of premium lens
    • 3.4.3. Opportunity
      • 3.4.3.1. Availability of advanced technologies
      • 3.4.3.2. Emerging nations
    • 3.4.4. Impact analysis
  • 3.5. PORTERS FIVE FORCES ANALYSIS
    • 3.5.1. Bargaining power of buyers
    • 3.5.2. Bargaining power of suppliers
    • 3.5.3. Threat of substitutes
    • 3.5.4. Threat of new entrants
    • 3.5.5. Competitive rivalry
  • 3.6. GOVERNMENT REGULATIONS
  • 3.7. CLINICAL TRIALS

CHAPTER 4 - GLOBAL INTRAOCULAR LENS MARKET, BY TYPE

  • 4.1. OVERVIEW
    • 4.1.1. Market size and forecast
  • 4.2. MONOFOCAL IOLS
    • 4.2.1. Key market trends
    • 4.2.2. Growth factors and opportunities
    • 4.2.3. Market size and forecast
  • 4.3. PREMIUM IOLS
    • 4.3.1. Key market trends
    • 4.3.2. Growth factors and opportunities
    • 4.3.3. Market size and forecast
      • 4.3.3.1. Toric intraocular lenses
      • 4.3.3.2. Market size and forecast
      • 4.3.3.3. Multifocal intraocular lenses
      • 4.3.3.4. Market size and forecast
      • 4.3.3.5. Accommodating intraocular lenses
      • 4.3.3.6. Market size and forecast
      • 4.3.3.7. Other IOLs
      • 4.3.3.8. Market size and forecast
        • 4.3.3.8.1. Blue light filtering IOLs
        • 4.3.3.8.2. Market size and forecast
        • 4.3.3.8.3. Phakic IOLs
        • 4.3.3.8.4. Market size and forecast
        • 4.3.3.8.5. Aspheric IOLs
        • 4.3.3.8.6. Market size and forecast

CHAPTER 5 - GLOBAL INTRAOCULAR LENSES MARKET BY END USER

  • 5.1. OVERVIEW
    • 5.1.1. Market size and forecast
  • 5.2. HOSPITALS
    • 5.2.1. Market size and forecast
  • 5.3. AMBULATORY SURGICAL CENTERS (ASCS)
    • 5.3.1. Market size and forecast
  • 5.4. OPTHALMOLOGY CLINICS
    • 5.4.1. Market size and forecast
  • 5.5. EYE RESEARCH INSTITUTES
    • 5.5.1. Market size and forecast

CHAPTER 6 - GLOBAL INTRAOCULAR LENS MARKET, BY MATERIAL

  • 6.1. OVERVIEW
    • 6.1.1. Market size and forecast
  • 6.2. POLYMETHYLMETHACRYLATE (PMMA)
    • 6.2.1. Market size and forecast
  • 6.3. SILICONE
    • 6.3.1. Market size and forecast
  • 6.4. HYDROPHOBIC ACRYLIC
    • 6.4.1. Market size and forecast

CHAPTER 7 GLOBAL INTRAOCULAR LENS MARKET, BY REGION

  • 7.1. OVERVIEW
    • 7.1.1. Market size and forecast
  • 7.2. NORTH AMERICA
    • 7.2.1. Key market trends
    • 7.2.2. Growth factors and opportunities
    • 7.2.3. Market size and forecast
    • 7.2.4. U.S. market size and forecast
    • 7.2.5. Canada market size and forecast
    • 7.2.6. Mexico market size and forecast
  • 7.3. EUROPE
    • 7.3.1. Key market trends
    • 7.3.2. Growth factors and opportunities
    • 7.3.3. Market size and forecast
    • 7.3.4. Germany market size and forecast
    • 7.3.5. France market size and forecast
    • 7.3.6. UK market size and forecast
    • 7.3.7. Italy market size and forecast
    • 7.3.8. Spain market size and forecast
    • 7.3.9. Netherlands market size and forecast
    • 7.3.10. Norway market size and forecast
    • 7.3.11. Russia market size and forecast
    • 7.3.12. Sweden market size and forecast
    • 7.3.13. Switzerland market size and forecast
    • 7.3.14. Rest of Europe market size and forecast
  • 7.4. ASIA-PACIFIC
    • 7.4.1. Key market trends
    • 7.4.2. Growth factors and opportunities
    • 7.4.3. Market size and forecast
    • 7.4.4. Japan market size and forecast
    • 7.4.5. China market size and forecast
    • 7.4.6. India market size and forecast
    • 7.4.7. Australia market size and forecast
    • 7.4.8. South Korea market size and forecast
    • 7.4.9. New Zealand market size and forecast
    • 7.4.10. Taiwan market size and forecast
    • 7.4.11. Thailand market size and forecast
    • 7.4.12. Rest of Asia-Pacific market size and forecast
  • 7.5. LAMEA
    • 7.5.1. Key market trends
    • 7.5.2. Growth factors and opportunities
    • 7.5.3. Market size and forecast
    • 7.5.4. Brazil market size and forecast
    • 7.5.5. Saudi Arabia market size and forecast
    • 7.5.6. South Africa market size and forecast
    • 7.5.7. Chile market size and forecast
    • 7.5.8. Columbia market size and forecast
    • 7.5.9. Egypt market size and forecast
    • 7.5.10. Iran market size and forecast
    • 7.5.11. Israel market size and forecast
    • 7.5.12. Turkey market size and forecast
    • 7.5.13. Venezuela market size and forecast
    • 7.5.14. Rest of LAMEA market size and forecast

CHAPTER 8 - COMPANY PROFILES

  • 8.1. ALCON (A NOVARTIS AG DIVISION)
    • 8.1.1. Company overview
    • 8.1.2. Company snapshot
    • 8.1.3. Operating business segments
    • 8.1.4. Business performance
    • 8.1.5. Key strategic moves and developments
    • 8.1.6. Strategy share (%)
  • 8.2. CARL ZEISS MEDITEC AG
    • 8.2.1. Company overview
    • 8.2.2. Company snapshot
    • 8.2.3. Operating business segments
    • 8.2.4. Business performance
    • 8.2.5. Key strategic moves and developments
    • 8.2.6. Strategy share (%)
  • 8.3. EYEKON MEDICAL, INC.
    • 8.3.1. Company overview
    • 8.3.2. Company snapshot
    • 8.3.3. Operating business segments
    • 8.3.4. Business performance
    • 8.3.5. Key strategic moves and developments
    • 8.3.6. Strategy share (%)
  • 8.4. HUMANOPTICS AG
    • 8.4.1. Company overview
    • 8.4.2. Company snapshot
    • 8.4.3. Operating business segments
    • 8.4.4. Business performance
    • 8.4.5. Key strategic moves and developments
    • 8.4.6. Strategy share (%)
  • 8.5. HOYA GROUP
    • 8.5.1. Company overview
    • 8.5.2. Company snapshot
    • 8.5.3. Operating business segments
    • 8.5.4. Business performance
    • 8.5.5. Key strategic moves and developments
    • 8.5.6. Strategy share (%)
  • 8.6. JOHNSON & JOHNSON
    • 8.6.1. Company overview
    • 8.6.2. Company snapshot
    • 8.6.3. Operating business segments
    • 8.6.4. Business performance
    • 8.6.5. Key strategic moves and developments
    • 8.6.6. Strategy share (%)
  • 8.7. LENSTEC, INC.
    • 8.7.1. Company overview
    • 8.7.2. Company snapshot
    • 8.7.3. Operating business segments
    • 8.7.4. Business performance
    • 8.7.5. Key strategic moves and developments
    • 8.7.6. Strategy share (%)
  • 8.8. RAYNER
    • 8.8.1. Company overview
    • 8.8.2. Company snapshot
    • 8.8.3. Operating business segments
    • 8.8.4. Business performance
    • 8.8.5. Key strategic moves and developments
    • 8.8.6. Strategy share (%)
  • 8.9. STAAR SURGICAL
    • 8.9.1. Company overview
    • 8.9.2. Company snapshot
    • 8.9.3. Operating business segments
    • 8.9.4. Business performance
    • 8.9.5. Key strategic moves and developments
    • 8.9.6. Strategy share (%)
  • 8.10. VALEANT
    • 8.10.1. Company overview
    • 8.10.2. Company snapshot
    • 8.10.3. Operating business segments
    • 8.10.4. Business performance
    • 8.10.5. Key strategic moves and developments
    • 8.10.6. Strategy share (%)

List of Tables

  • TABLE 1. GLOBAL VISION IMPAIRMENT BY AGE, 2010
  • TABLE 2. GLOBAL INTRAOCULAR LENS MARKET, BY TYPE ($MILLION), 2014-2022
  • TABLE 3. GLOBAL MONOFOCAL INTRAOCULAR LENSES MARKET, BY REGION ($MILLION), 2014-2022
  • TABLE 4. NORTH AMERICA MONOFOCAL INTRAOCULAR LENSES MARKET, BY COUNTRY ($MILLION), 2014-2022
  • TABLE 5. EUROPE MONOFOCAL INTRAOCULAR LENSES MARKET, BY COUNTRY ($MILLION), 2014-2022
  • TABLE 6. ASIA-PACIFIC MONOFOCAL INTRAOCULAR LENSES MARKET, BY COUNTRY ($MILLION), 2014-2022
  • TABLE 7. LAMEA MONOFOCAL INTRAOCULAR LENSES MARKET, BY COUNTRY ($MILLION), 2014-2022
  • TABLE 8. GLOBAL PREMIUM INTRAOCULAR LENSES MARKET, BY TYPE ($MILLION), 2014-2022
  • TABLE 9. GLOBAL PREMIUM INTRAOCULAR LENSES MARKET, BY REGION ($MILLION), 2014-2022
  • TABLE 10. NORTH AMERICA PREMIUM INTRAOCULAR LENSES MARKET, BY COUNTRY ($MILLION), 2014-2022
  • TABLE 11. EUROPE PREMIUM INTRAOCULAR LENSES MARKET, BY COUNTRY ($MILLION), 2014-2022
  • TABLE 12. ASIA-PACIFIC PREMIUM INTRAOCULAR LENSES MARKET, BY COUNTRY($MILLION), 2014-2022
  • TABLE 13. LAMEA PREMIUM INTRAOCULAR LENSES MARKET, BY COUNTRY ($MILLION), 2014-2022
  • TABLE 14. GLOBAL OTHER INTRAOCULAR LENSES MARKET, BY TYPE ($MILLION), 2014-2022
  • TABLE 15. GLOBAL INTRAOCULAR LENS MARKET, BY END-USER ($MILLION), 2014-2022
  • TABLE 16. NORTH AMERICA INTRAOCULAR LENSES MARKET, BY END-USER ($MILLION), 2014-2022
  • TABLE 17. EUROPE INTRAOCULAR LENSES MARKET, BY END-USER ($MILLION), 2014-2022
  • TABLE 18. ASIA-PACIFIC INTRAOCULAR LENSES MARKET, BY END-USER ($MILLION), 2014-2022
  • TABLE 19. LAMEA INTRAOCULAR LENSES MARKET, BY END-USER ($MILLION), 2014-2022
  • TABLE 20. GLOBAL INTRAOCULAR LENS MARKET FOR HOSPITALS, BY REGION ($MILLION), 2014-2022
  • TABLE 21. GLOBAL INTRAOCULAR LENS MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION ($MILLION), 2014-2022
  • TABLE 22. GLOBAL INTRAOCULAR LENS MARKET FOR OPTHALMOLOGY CLINICS, BY REGION ($MILLION), 2014-2022
  • TABLE 23. GLOBAL INTRAOCULAR LENS MARKET FOR EYE RESEARCH INSTITUTE, BY REGION ($MILLION), 2014-2022
  • TABLE 24. GLOBAL INTRAOCULAR LENS MARKET, BY MATERIAL ($MILLION), 2014-2022
  • TABLE 25. NORTH AMERICA INTRAOCULAR LENSES MARKET, BY MATERIAL ($MILLION), 2014-2022
  • TABLE 26. EUROPE INTRAOCULAR LENSES MARKET, BY MATERIAL ($MILLION), 2014-2022
  • TABLE 27. ASIA-PACIFIC INTRAOCULAR LENSES MARKET, BY MATERIAL ($MILLION), 2014-2022
  • TABLE 28. LAMEA INTRAOCULAR LENSES MARKET, BY MATERIAL ($MILLION), 2014-2022
  • TABLE 29. GLOBAL INTRAOCULAR LENS MARKET FOR POLY METHYL METHACRYLATE, BY REGION ($MILLION), 2014-2022
  • TABLE 30. GLOBAL INTRAOCULAR LENS MARKET FOR SILICONE, BY REGION ($MILLION), 2014-2022
  • TABLE 31. GLOBAL INTRAOCULAR LENS MARKET FOR HYDROPHOBIC ACRYLIC, BY REGION ($MILLION), 2014-2022
  • TABLE 32. GLOBAL INTRAOCULAR LENS MARKET, BY REGION ($MILLION), 2014-2022
  • TABLE 33. GLOBAL INTRAOCULAR LENS MARKET, BY REGION (THOUSAND UNITS), 2014-2022
  • TABLE 34. NORTH AMERICA INTRAOCULAR LENSES MARKET, BY COUNTRY ($MILLION), 2014-2022
  • TABLE 35. NORTH AMERICA INTRAOCULAR LENSES MARKET, BY TYPE ($MILLION), 2014-2022
  • TABLE 36. NORTH AMERICA INTRAOCULAR LENSES MARKET, BY COUNTRY (THOUSAND UNITS), 2014-2022
  • TABLE 37. EUROPE INTRAOCULAR LENSES MARKET, BY COUNTRY ($MILLION), 2014-2022
  • TABLE 38. EUROPE INTRAOCULAR LENSES MARKET, BY TYPE ($MILLION), 2014-2022
  • TABLE 39. EUROPE INTRAOCULAR LENSES MARKET, BY COUNTRY (THOUSAND UNITS), 2014-2022
  • TABLE 40. ASIA-PACIFIC INTRAOCULAR LENSES MARKET, BY COUNTRY ($MILLION), 2014-2022
  • TABLE 41. ASIA-PACIFIC INTRAOCULAR LENSES MARKET, BY TYPE ($MILLION), 2014-2022
  • TABLE 42. ASIA-PACIFIC INTRAOCULAR LENSES MARKET, BY COUNTRY (THOUSAND UNITS), 2014-2022
  • TABLE 43. LAMEA INTRAOCULAR LENSES MARKET, BY COUNTRY ($MILLION), 2014-2022
  • TABLE 44. LAMEA INTRAOCULAR LENSES MARKET, BY TYPE ($MILLION), 2014-2022
  • TABLE 45. LAMEA INTRAOCULAR LENSES MARKET, BY COUNTRY (THOUSAND UNITS), 2014-2022
  • TABLE 46. ALCON: COMPANY SNAPSHOT
  • TABLE 47. ALCON: OPERATING SEGMENTS
  • TABLE 48. ZEISS: COMPANY SNAPSHOT
  • TABLE 49. ZEISS: OPERATING SEGMENTS
  • TABLE 50. EYEKON: COMPANY SNAPSHOT
  • TABLE 51. EYEKON: OPERATING SEGMENTS
  • TABLE 52. HUMANOPTICS: COMPANY SNAPSHOT
  • TABLE 53. HUMANOPTICS: OPERATING SEGMENTS
  • TABLE 54. HOYA: COMPANY SNAPSHOT
  • TABLE 55. HOYA: OPERATING SEGMENTS
  • TABLE 56. J&J: COMPANY SNAPSHOT
  • TABLE 57. J&J: OPERATING SEGMENTS
  • TABLE 58. LENSTEC: COMPANY SNAPSHOT
  • TABLE 59. LENSTEC: OPERATING SEGMENTS
  • TABLE 60. RAYNER: COMPANY SNAPSHOT
  • TABLE 61. RAYNER: OPERATING SEGMENTS
  • TABLE 62. STAAR: COMPANY SNAPSHOT
  • TABLE 63. STAAR: OPERATING SEGMENTS
  • TABLE 64. VALEANT: COMPANY SNAPSHOT
  • TABLE 65. VALEANT: OPERATING SEGMENTS

List of Figures

  • FIGURE 1. INTRAOCULAR LENS MARKET, BY TYPE, 2015 VS 2022 ($MILLION)
  • FIGURE 2. MARKET SEGMENTATION
  • FIGURE 3. TOP INVESTMENT POCKETS
  • FIGURE 4. MARKET SHARE ANALYSIS, 2015
  • FIGURE 5. MAJOR CAUSES OF VISUAL IMPAIRMENT WORLDWIDE, 2010
  • FIGURE 6. MAJOR CAUSES OF BLINDNESS WORLDWIDE, 2010
  • FIGURE 7. GLOBAL IMPAIRMENT BY WHO REGION AND COUNTRY, 2010
  • FIGURE 8. BARGAINING POWER OF BUYERS, 2015
  • FIGURE 9. BARGAINING POWER OF SUPPLIERS, 2015
  • FIGURE 10. THREAT OF SUBSTITUTES, 2015
  • FIGURE 11. THREAT OF NEW ENTRANTS, 2015
  • FIGURE 12. COMPETITIVE RIVALRY, 2015
  • FIGURE 13. GEOGRAPHICAL DISTRIBUTION OF IOL CLINICAL TRIALS
  • FIGURE 14. IOL CLINICAL TRIALS, BY COUNTRY
  • FIGURE 15. IOL CLINICAL TRIALS, BY PHASE
  • FIGURE 16. TORIC IOL MARKET ($MILLION), 2014-2022
  • FIGURE 17. MULTIFOCAL IOL MARKET ($MILLION), 2014-2022
  • FIGURE 18. ACCOMODATING IOL MARKET ($MILLION), 2014-2022
  • FIGURE 19. BLUE-LIGHT FILTERING IOL MARKET ($MILLION), 2014-2022
  • FIGURE 20. PHAKIC IOL MARKET ($MILLION), 2014-2022
  • FIGURE 21. ASPHERIC IOL MARKET ($MILLION), 2014-2022
  • FIGURE 22. U.S. IOL MARKET ($MILLION), 2014-2022
  • FIGURE 23. CANADA IOL MARKET ($MILLION), 2014-2022
  • FIGURE 24. MEXICO IOL MARKET ($MILLION), 2014-2022
  • FIGURE 25. CATARACT SURGERY PROCEDURES PERFORMED IN EUROPE, BY DEMOGRAPHICS, 2012
  • FIGURE 26. GERMANY IOL MARKET ($MILLION), 2014-2022
  • FIGURE 27. FRANCE IOL MARKET ($MILLION), 2014-2022
  • FIGURE 28. UK IOL MARKET ($MILLION), 2014-2022
  • FIGURE 29. ITALY IOL MARKET ($MILLION), 2014-2022
  • FIGURE 30. SPAIN IOL MARKET ($MILLION), 2014-2022
  • FIGURE 31. NETHERLANDS IOL MARKET ($MILLION), 2014-2022
  • FIGURE 32. NORWAY IOL MARKET ($MILLION), 2014-2022
  • FIGURE 33. RUSSIA IOL MARKET ($MILLION), 2014-2022
  • FIGURE 34. SWEDEN IOL MARKET ($MILLION), 2014-2022
  • FIGURE 35. SWITZERLAND IOL MARKET ($MILLION), 2014-2022
  • FIGURE 36. REST OF EUROPE IOL MARKET ($MILLION), 2014-2022
  • FIGURE 37. LEADING CAUSES OF BLINDNESS IN JAPAN, 2013
  • FIGURE 38. LEADING CAUSES OF BLINDNESS IN INDIA, 2014
  • FIGURE 39. JAPAN IOL MARKET ($MILLION), 2014-2022
  • FIGURE 40. CHINA IOL MARKET ($MILLION), 2014-2022
  • FIGURE 41. INDIA IOL MARKET ($MILLION), 2014-2022
  • FIGURE 42. AUSTRALIA IOL MARKET ($MILLION), 2014-2022
  • FIGURE 43. SOUTH KOREA IOL MARKET ($MILLION), 2014-2022
  • FIGURE 44. NEW ZEALAND IOL MARKET ($MILLION), 2014-2022
  • FIGURE 45. TAIWAN IOL MARKET ($MILLION), 2014-2022
  • FIGURE 46. THAILAND IOL MARKET ($MILLION), 2014-2022
  • FIGURE 47. REST OF ASIA-PACIFIC IOL MARKET ($MILLION), 2014-2022
  • FIGURE 48. BRAZIL IOL MARKET ($MILLION), 2014-2022
  • FIGURE 49. SAUDI ARABIA IOL MARKET ($MILLION), 2014-2022
  • FIGURE 50. SOUTH AFRICA IOL MARKET ($MILLION), 2014-2022
  • FIGURE 51. CHILE IOL MARKET ($MILLION), 2014-2022
  • FIGURE 52. COLUMBIA IOL MARKET ($MILLION), 2014-2022
  • FIGURE 53. EGYPT IOL MARKET ($MILLION), 2014-2022
  • FIGURE 54. IRAN IOL MARKET ($MILLION), 2014-2022
  • FIGURE 55. ISRAEL IOL MARKET ($MILLION), 2014-2022
  • FIGURE 56. TURKEY IOL MARKET ($MILLION), 2014-2022
  • FIGURE 57. VENEZUELA IOL MARKET ($MILLION), 2014-2022
  • FIGURE 58. REST OF LAMEA IOL MARKET ($MILLION), 2014-2022
  • FIGURE 59. ALCON: FINANCIALS
  • FIGURE 60. ZEISS: FINANCIALS
  • FIGURE 61. EYEKON: FINANCIALS
  • FIGURE 62. HUMANOPTICS: FINANCIALS
  • FIGURE 63. HOYA: FINANCIALS
  • FIGURE 64. J&J: FINANCIALS
  • FIGURE 65. LENSTEC: FINANCIALS
  • FIGURE 66. RAYNER: FINANCIALS
  • FIGURE 67. STAAR: FINANCIALS
  • FIGURE 68. VALEANT: FINANCIALS
Back to Top